Stocks have paused since Monday, when the S&P 500 index hit its 46 th record close this year. The index has almost doubled in ...

One chief equity strategist says that the S&P 500 Index could face a significant decline next year following its 2024 gains.

AbbVie has been reporting an earnings decline because its former lead drug, Humira, lost patent-protected market exclusivity ...

The S&P 500 defies the odds and mounting risks to continue its trend. The market broke above critical support in late ...

The S&P 500 advanced 0.8% on Monday, adding to the benchmark index's all-time high Friday for a second straight record close.

The S&P 500 index was up slightly Wednesday, with sector gains led by utilities and financials, according to FactSet data, at last check. The utilities sector was up 1.1% Wednesday morning, while the ...

Short interest for healthcare stocks in S&P 500 increased during September end vs. last month, with Moderna being most ...

MicroStrategy stock has outperformed all S&P 500 firms since 2020, but despite its robust performance, a listing in the index ...

(Reuters) - UBS Global Research on Tuesday raised its year-end target for the benchmark S&P 500 index to 5,850 points from an ...

In fact, the S&P 500 just generated its best January-through-September returns since 1997. History suggests there's more to ...

S&P 500 futures are up 0.1%. Dow Jones Industrial Average futures are down 0.1%. Nasdaq 100 futures are adding 0.2%. On Tuesday, the Dow Jones Industrial Average fell 325 points, or 0.75%, to 42,740, ...

But for many investors, S&P 500 index funds remain the overwhelming favorite when it comes to long-term investing. The S&P 500 index tracks the prices of the 500 largest U.S. public companies ...